Transition to a virtual multidisciplinary tumor board during the <scp>COVID</scp>‐19 pandemic: University of Pittsburgh experienceHarish Dharmarajan, Mark Kubik, Jennifer L. Anderson et al.|Head & Neck|2020Cited by 88
Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland MalignanciesBrian J. Gebhardt, David A. Clump, Umamaheswar Duvvuri et al.|American Journal of Clinical Oncology|2017Cited by 47
Adjuvant stereotactic body radiotherapy ± cetuximab following salvage surgery in previously irradiated head and neck cancerJohn A. Vargo, Dwight E. Heron, Gregory J. Kubicek et al.|The Laryngoscope|2013Cited by 40
Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinomaWilliam G. Albergotti, Robert L. Ferris, Kara S. Davis et al.|Oral Oncology|2016Cited by 25
Tumor volume as a predictor of survival in human papillomavirus–positive oropharyngeal cancerKara S. Davis, Robert L. Ferris, Chwee Ming Lim et al.|Head & Neck|2015Cited by 23